Substance Use Disorder Statistics in Kansas

Substance Use Disorder (SUD) is a significant public health challenge both nationally and within Kansas. Across the United States, nearly 48.5 million people aged 12 or older had an SUD in the past year^[4], which translates to approximately 17.1% of this population^[4]. Annually, around 20 million Americans meet the criteria for SUDs^[3]. In Kansas, the issue is similarly pressing, with some reports indicating that nearly one in five adults have a diagnosable substance use disorder^[9]. Understanding these statistics is the first step in addressing the complex web of prevention, treatment, and recovery within the state.

The burden of substance use disorder is not distributed evenly across the population. Nationally, young adults aged 18 to 25 have the highest prevalence of SUD at 27.1%^[4], compared to 8.5% for adolescents and 16.6% for adults over 26^[4]. In Kansas, similar patterns emerge, with notable differences in SUD rates based on age, gender, and geography. These disparities underscore the need for targeted prevention and outreach efforts for the state’s most vulnerable groups.

Despite the clear need, accessing treatment for SUD in Kansas is fraught with challenges. Nationally, only a small fraction, under 10–20%, of individuals with SUDs receive specialty treatment^[3]. This treatment gap is influenced by numerous factors, including stigma, denial, or an underestimation of the disorder’s severity, which are significant barriers to care^[3]. In Kansas, these issues are compounded by economic challenges, social isolation in rural communities, and systemic gaps in the healthcare infrastructure^[1].

The nature of substance use disorder in Kansas is continuously evolving. Local law enforcement data have noted a troubling increase in opioid overdose deaths over the past five years^[15]. In response to these and other trends, the state has increased its focus on intervention, with a 12% increase in state-sponsored initiatives aimed at expanding treatment provider networks since 2020^[1]. Tracking these shifts is vital for adapting public health strategies effectively.

Economic realities play a crucial role in the landscape of SUD treatment. Nationally, drug-related problems cost the United States hundreds of billions of dollars each year in lost productivity, healthcare, and criminal justice expenses^[4]. In Kansas, private insurance is the dominant funding source for SUD treatment^[9], but issues like state funding levels, workforce compensation, and the financial health of rural hospitals create significant systemic hurdles to providing adequate care.